Compassionate use of medicinal products in Europe: current status and perspectives

Editorial

Mussa Rahbari et al. Bull World Health Organ. 2011.

. 2011 Mar 1;89(3):163.

doi: 10.2471/BLT.10.085712.

No abstract available

References

1. Regulation (EC) no. 726/2004 of the European Parliament and of the Council (OJ L 136, 30.4.2004). Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2004R0726:... [accessed 20 January 2011].
1. Guideline on compassionate use of medicinal products, pursuant to Article 83 of Regulation (EC) no. 726/2004 (doc ref: EMEA/27170/2006). London: European Medicines Agency; 2007. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_ pro... [accessed 20 January 2011].
1. Compassionate use. London: European Medicines Agency; 2010. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/gen... [accessed 20 January 2011].
1. Conditions of use, conditions for distribution and patients targeted and conditions for safety monitoring addressed to member states for Tamiflu IV available for compassionate use. London: European Medicines Agency; 2010. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2010/01/WC500... [accessed 20 January 2011].
1. Summary on compassionate use for Tamiflu IV. London: European Medicines Agency; 2010. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2010/05/WC500... [accessed 20 January 2011].